In vivo KCNQ1-suppression-replacement gene therapy in transgenic LQT1 rabbits restores a physiological QT interval at baseline and under catecholamine infusion

8 April 2024 (13:30 - 14:15)
Organised by: Logo
Congress Presentation Part of: Miscellaneous 2 Cardiac Diseases EHRA Premium Access EHRA 2024 European Heart Rhythm Association (EHRA)

ESC 365 is supported by

ESC 365 is supported by